We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Janssen made the observation in one of 19 letters filed in response to a request for comments on how OND could promote effective drug development programs. Read More
Rochester Drug Co-operative, one of the country’s top ten drug distributors, is pulling the plug on its opioid distribution operations after running into serious legal and regulatory troubles. Read More
Eli Lilly plans to launch two new cheaper insulin products amid criticism about the availability of its lower-cost insulins on pharmacy shelves. Read More
Biogen has agreed to purchase Pfizer’s early-stage neurological disease drug for $75 million plus royalties and up to $635 million in future payments. The acquisition of PF-05251749 marks the latest move by Biogen into potential treatments for neurological diseases. Read More
The European Commission has approved AbbVie’s $63 billion acquisition of Allergan on condition that the companies sell off Allergan’s investigational treatment for inflammatory bowel disease (IBD). Read More
Bristol-Myers Squibb and Sanofi have filed a complaint against the state of Hawaii over a lawsuit that seeks massive fines against the drugmakers for failing to include a warning in labeling for their anti-blood clotting drug Plavix (clopidogrel). Read More
Hospira prevailed this week in a Florida lawsuit that alleged the Pfizer subsidiary falsely advertised its epinephrine products as being FDA approved. Read More